Factors associated with change in the magnitude of clinical benefit of anti-cancer drugs in the post-marketing period.

Authors

null

Aida Bujosa Rodríguez

Hospital de Sant Pau, Barcelona, Spain

Aida Bujosa Rodríguez , Consolacion Molto , Thomas J Hwang , Kerstin Noëlle Vokinger , Jose Carlos Tapia , Ignasi J. Gich Saladich , Arnoud J. Templeton , Agusti Barnadas , Eitan Amir , Ariadna Tibau

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Quality Improvement

Citation

J Clin Oncol 38: 2020 (suppl; abstr 7052)

DOI

10.1200/JCO.2020.38.15_suppl.7052

Abstract #

7052

Poster Bd #

324

Abstract Disclosures

Similar Posters

First Author: Antonio Tito Fojo

First Author: Mark Lythgoe